The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
The global Stem Cell Therapy market was valued at US$ 479.5 million in 2023 and is anticipated to reach US$ 1711.9 million by 2030, witnessing a CAGR of 19.7% during the forecast period 2024-2030.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
Report Scope
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List)
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Molmed
- Takeda (TiGenix)
Segment by Type
- Autologous
- Allogeneic
Segment by Application
- Musculoskeletal Disorder
- Wounds & Injuries
- Cornea
- Cardiovascular Diseases
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil,Turkey, GCC Countries)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cornea
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2019-2030)
2.2 Stem Cell Therapy Growth Trends by Region
2.2.1 Global Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2023
3.5 Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Therapy Market Size (2019-2030)
6.2 North America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics
11.1.1 Osiris Therapeutics Company Detail
11.1.2 Osiris Therapeutics Business Overview
11.1.3 Osiris Therapeutics Stem Cell Therapy Introduction
11.1.4 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2019-2024)
11.1.5 Osiris Therapeutics Recent Development
11.2 NuVasive
11.2.1 NuVasive Company Detail
11.2.2 NuVasive Business Overview
11.2.3 NuVasive Stem Cell Therapy Introduction
11.2.4 NuVasive Revenue in Stem Cell Therapy Business (2019-2024)
11.2.5 NuVasive Recent Development
11.3 Chiesi Pharmaceuticals
11.3.1 Chiesi Pharmaceuticals Company Detail
11.3.2 Chiesi Pharmaceuticals Business Overview
11.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Introduction
11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2019-2024)
11.3.5 Chiesi Pharmaceuticals Recent Development
11.4 JCR Pharmaceutical
11.4.1 JCR Pharmaceutical Company Detail
11.4.2 JCR Pharmaceutical Business Overview
11.4.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.4.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2019-2024)
11.4.5 JCR Pharmaceutical Recent Development
11.5 Pharmicell
11.5.1 Pharmicell Company Detail
11.5.2 Pharmicell Business Overview
11.5.3 Pharmicell Stem Cell Therapy Introduction
11.5.4 Pharmicell Revenue in Stem Cell Therapy Business (2019-2024)
11.5.5 Pharmicell Recent Development
11.6 Medi-post
11.6.1 Medi-post Company Detail
11.6.2 Medi-post Business Overview
11.6.3 Medi-post Stem Cell Therapy Introduction
11.6.4 Medi-post Revenue in Stem Cell Therapy Business (2019-2024)
11.6.5 Medi-post Recent Development
11.7 Anterogen
11.7.1 Anterogen Company Detail
11.7.2 Anterogen Business Overview
11.7.3 Anterogen Stem Cell Therapy Introduction
11.7.4 Anterogen Revenue in Stem Cell Therapy Business (2019-2024)
11.7.5 Anterogen Recent Development
11.8 Molmed
11.8.1 Molmed Company Detail
11.8.2 Molmed Business Overview
11.8.3 Molmed Stem Cell Therapy Introduction
11.8.4 Molmed Revenue in Stem Cell Therapy Business (2019-2024)
11.8.5 Molmed Recent Development
11.9 Takeda (TiGenix)
11.9.1 Takeda (TiGenix) Company Detail
11.9.2 Takeda (TiGenix) Business Overview
11.9.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.9.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2019-2024)
11.9.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
